Article ID Journal Published Year Pages File Type
2142616 Lung Cancer 2011 5 Pages PDF
Abstract
These results provide clinical evidence to support the notion that BRMS1 is a NSCLC metastasis suppressor gene. Measuring methylation status of BRMS1 promotor is a useful marker for identifying NSCLC patients with worse disease-free survival.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Promoter methylation of BRMS1 correlates with smoking history and poor survival in non-small cell lung cancer patients
Authors
, , , ,